V CompBrief BY VELARION

Executive Vice President, Head of Research and Development · ACADIA PHARMACEUTICALS INC (ACAD)

Elizabeth Thompson

A named executive officer of ACADIA PHARMACEUTICALS in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$2,888,383

FY2024: $4,261,944

4th of 5 named executive officers at Acadia Pharmaceuticals by FY2025 total.

5 named officers on file for ACADIA PHARMACEUTICALS, FY2025

See an example →

What this number hides

The filing gives the total. ACADIA PHARMACEUTICALS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how ACADIA PHARMACEUTICALS’s whole pay program stands against its peers

  • ACADIA PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ACAD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2026 (DEF 14A).

Free

Get Elizabeth Thompson’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Elizabeth Thompson and every company like it: Velarion Intel, free for 3 days, no card →

Elizabeth Thompson compensation by year

ACADIA PHARMACEUTICALS Summary Compensation Table · all 2 fiscal years held
In US dollars, as ACADIA PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$281,884$647,325
Bonus$0$0
Stock awards$986,878$925,611
Option awards$2,860,444$923,958
Non-equity incentive$117,399$372,272
Pension and deferred compensation$0$0
All other$15,339$19,217
Total$4,261,944$2,888,383

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ACADIA PHARMACEUTICALS INC DEF 14A filed April 24, 2026, accession 0001193125-26-174163, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ACADIA PHARMACEUTICALS INC filed document, accession 0001193125-26-174163. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

$4.3M
$2.9M
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU114,955$3,070,448—
PSU91,405$2,441,428—
RSU64,544$1,723,970—
RSU26,861$717,457—
RSU21,200$566,252—
PSU21,200$566,252—
Option209,627—$15.29
Option91,395—$17.23

Per the Outstanding Equity Awards at Fiscal Year-End table in ACADIA PHARMACEUTICALS INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

ACADIA PHARMACEUTICALS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Catherine Owen AdamsChief Executive Officer$8,256,518
Mark SchneyerExecutive Vice President, Chief Financial Officer$3,119,408
Jennifer RhodesExecutive Vice President, Chief Legal Officer and Secretary$2,927,897
Elizabeth Thompson · this pageExecutive Vice President, Head of Research and Development$2,888,383
Thomas GarnerExecutive Vice President, Chief Commercial Officer$857,023

Elizabeth Thompson's compensation dossier, ACADIA PHARMACEUTICALS

You have read Elizabeth Thompson's totals and holdings. The dossier adds each equity grant ACADIA PHARMACEUTICALS disclosed for Elizabeth Thompson and ACADIA PHARMACEUTICALS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full ACADIA PHARMACEUTICALS compensation record

free company brief
ACADIA PHARMACEUTICALS INC (ACAD) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within ACADIA PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ACADIA PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order ACADIA PHARMACEUTICALS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ACADIA PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order ACAD

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Elizabeth Thompson's compensation dossier